Table 1.
The alterations of acyl-PG species annotated based on ESI-TOF-MS
| Sum Composition | Molecular lipid Information | FCa | P-value |
|---|---|---|---|
| acyl-PG 42:0 | acyl-PG 14:0_16:0/12:0 | 0.80 | 2.20E-01 |
| acyl-PG 44:0 | acyl-PG 14:0_16:0/14:0 + acyl-PG 16:0_16:0/12:0 + acyl-PG 12:0_16:0/16:0 | 1.09 | 6.33E-01 |
| acyl-PG 46:0 | acyl-PG 14:0_16:0/16:0 | 2.14 ↑ | 1.91E-03 |
| acyl-PG 48:0 | acyl-PG 16:0_16:0/16:0 | 3.99 ↑ | 1.24E-03 |
| acyl-PG 50:0 | acyl-PG 16:0_18:0/16:0 | 3.74 ↑ | 1.62E-03 |
| acyl-PG 42:1 | acyl-PG 14:0_16:1/12:0 | 1.15 | 1.54E-01 |
| acyl-PG 44:1 | acyl-PG 16:0_16:1/12:0 | 0.62 ↓ | 3.47E-04 |
| acyl-PG 46:1 | acyl-PG 16:0_16:1/14:0 + acyl-PG 16:0_18:1/12:0 + acyl 14:0_16:1/16:0 + acyl 14:0_16:0/16:1 | 0.90 | 3.16E-01 |
| acyl-PG 48:1 | acyl-PG 16:0_16:1/16:0 | 1.78 ↑ | 1.12E-03 |
| acyl-PG 50:1 | acyl-PG 16:0_18:1/16:0 | 2.93 ↑ | 9.80E-04 |
| acyl-PG 52:1 | acyl-PG 18:0_18:1/16:0 | 3.21 ↑ | 3.03E-03 |
| acyl-PG 44:2 | acyl-PG 14:0_14:1/16:1 + acyl-PG 12:0_16:1/16:1 + acyl-PG 12:0_14:1/18:1 | 0.76 | 1.01E-02 |
| acyl-PG 46:2 | acyl-PG 16:1_18:1/12:0 + acyl-PG 14:0_18:1/14:1 + acyl-PG 14:0_16:1/16:1 | 0.64 ↓ | 8.60E-03 |
| acyl-PG 48:2 | acyl-PG 16:0_16:1/16:1 | 0.94 | 6.60E-01 |
| acyl-PG 50:2 | acyl-PG 16:0_18:1/16:1 + acyl-PG 16:1_18:1/16:0 + acyl-PG 16:0_16:1/18:1 | 1.55 ↑ | 1.11E-02 |
| acyl-PG 52:2 | acyl-PG 16:0_18:1/18:1 + acyl-PG 18:1_18:1/16:0 | 2.55 ↑ | 1.04E-03 |
| acyl-PG 54:2 | acyl-PG 18:1_18:0/18:1 | 3.23 ↑ | 3.06E-03 |
| acyl-PG 46:3 | acyl-PG 16:1_16:1/14:1 | 0.62 ↓ | 1.04E-02 |
| acyl-PG 48:3 | acyl-PG 16:1_18:1/14:1 + acyl-PG 16:1_16:1/16:1 | 0.88 | 4.74E-01 |
| acyl-PG 50:3 | acyl-PG 16:1_18:1/16:1 | 1.15 | 3.73E-01 |
| acyl-PG 52:3 | acyl-PG 16:1_18:1/18:1 + acyl-PG 18:1_18:1/16:1 | 1.72 | 5.44E-02 |
| acyl-PG 54:3 | acyl-PG 18:1_18:1/18:1 | 2.88 ↑ | 2.97E-02 |
a
The fold change of the lipid levels in the crrB mutant compared with the wild type. Data are given in supplemental File S2.